Bedoya-López, A. F., Ahn, S., Ensenyat-Mendez, M., Orozco, J. I. J., Iñiguez-Muñoz, S., Llinàs-Arias, P., … DiNome, M. L. (2026). Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer. NPJ Precis Oncol, 10(1). https://doi.org/10.1038/s41698-026-01367-4

Bedoya-López, Andrés F., Sookyung Ahn, Miquel Ensenyat-Mendez, Javier I. J. Orozco, Sandra Iñiguez-Muñoz, Pere Llinàs-Arias, Samantha M. Thomas, et al. “Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.” NPJ Precis Oncol 10, no. 1 (March 30, 2026). https://doi.org/10.1038/s41698-026-01367-4.

Bedoya-López AF, Ahn S, Ensenyat-Mendez M, Orozco JIJ, Iñiguez-Muñoz S, Llinàs-Arias P, et al. Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer. NPJ Precis Oncol. 2026 Mar 30;10(1).

Bedoya-López, Andrés F., et al. “Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.” NPJ Precis Oncol, vol. 10, no. 1, Mar. 2026. Pubmed, doi:10.1038/s41698-026-01367-4.

Bedoya-López AF, Ahn S, Ensenyat-Mendez M, Orozco JIJ, Iñiguez-Muñoz S, Llinàs-Arias P, Thomas SM, Baker JL, Sullivan PS, Makker J, Steele JB, Kurian SM, Marzese DM, DiNome ML. Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer. NPJ Precis Oncol. 2026 Mar 30;10(1).